The drug company Servier on Monday launched an appeal in a Paris court against an earlier decision in the so-called Mediator affair. The group was heavily fined in 2021 for aggravated fraud and involuntary manslaughter in the production and marketing of a slimming drug.
Launched in 1976, Mediator was intended to treat excess weight in diabetes patients. The product was also widely prescribed as a weight-loss aide for otherwise healthy patients.
